Ignite Creation Date:
2025-12-24 @ 5:12 PM
Ignite Modification Date:
2026-01-01 @ 8:25 AM
Study NCT ID:
NCT03762850
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-06-10
First Post:
2018-11-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy
Sponsor:
Travere Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-12-11
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-07
Completion Date Type:
ESTIMATED
First Submit Date:
2018-11-27
First Submit QC Date:
None
Study First Post Date:
2018-12-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-06-11
Results First Submit QC Date:
None
Results First Post Date:
2024-07-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-06
Last Update Post Date:
2025-06-10
Last Update Post Date Type:
ACTUAL